Chris Lucas

Senior Vice President, Financial Planning and Operational Excellence

Chris joined Tessera in 2022 as Senior Vice President of Financial Planning and Operational Excellence. Having over 16 years of experience across multiple industries, Mr. Lucas brings a strong background in financial management, leading and developing finance teams, operational excellence, strategic insights/planning, capital raising, and manufacturing strategy. As a member of the Tessera leadership team, he is responsible for Financial Planning & Analysis (FP&A), Procurement & Sourcing, and Manufacturing Strategy/Planning.

Before joining Tessera, Chris was the Head of Strategy and Business Operations at 2seventy bio (post bluebird bio spin-out) and previously Interim CFO of bluebird bio pre-spin remain-co. Most recently, he oversaw operating governance, clinical manufacturing construction, spin-off readiness, strategic planning & insights, FP&A, and procurement/sourcing. He originally joined bluebird bio as VP, Finance (FP&A + Global Procurement & Sourcing). Before bluebird, Chris was the Executive Director, Global FP&A at Amicus Therapeutics where he grew and developed a Global FP&A team to support the global commercial launch of Galafold, development of biologics, and multiple acquisitions to build a Gene Therapy Portfolio/Pipeline. Prior experience includes business formation consulting, hedge fund (deal origination), investment banking and equity research.

Chris has a B.B.A in Finance and Accounting and an M.B.A., both from St. Bonaventure University.